For companies developing new medicines, devices and products, one of London's major selling points is its capacity to support early engagement, collaborative research and wide-ranging, robust clinical trials

World-class scientific, clinical and investigator expertise

London is home to teaching hospitals with world-leading infrastructure and a global reputation, offering best practice models of collaborative research, early phase transitional research partnerships and capability to deliver on adaptive design studies and rare diseases.

Accessible, ethnically diverse patient population

  • 40% of London’s population come from Asian, Black, Chinese or mixed background compared to 13% nationally (Office for National Statistics 2014)
  • Research institutes and trusts have invested in programmes to encourage patient public involvement (PPI) and consequently there is a high public awareness of the value of research
  • London regions have developed a ‘Consent to Contact’ programme to enable GPs and health care professionals to identify and contact patients for potential inclusion into relevant studies. This will result in faster identification and recruitment of patients

High performance and operational delivery according to international quality standards

  • The National Institute of Health Research (NIHR) funds a range of centres and facilities focused on translating findings from basic and laboratory-based science into the clinic, and ultimately into new treatments across the spectrum of disease and therapeutic areas. Additionally the NIHR Clinical Research Network (CRN) provides free support to help the life sciences industry deliver high quality research in the NHS
  • London has a large number of research-active sites, many connected via a ‘hub and spoke’ model and a single contract, resulting in faster set up and trial management
  • London-based Academic Research Organisations capable of successfully co-ordinating studies on behalf of Sponsor via an established network of high-performing primary and secondary care research sites across a range of disease areas

Effective recruitment

  • Between 2010/11 and 2014/15, 3,565,517 patients were recruited to NIHR studies; of those 744,157 (21%) were recruited in London
  • In 2014/15, 22% of all patients recruited to NIHR portfolio studies were recruited in London
  • In 2014/15 6,575 patients were recruited to commercial studies in London – 18% of the UK total

Speed of set up

84% of commercial study sites received permission for site set up within 40 days

29 First Global Patients recruited in the pan-London areas since 2011, 28% of UK global firsts; six global firsts were recruited in London in 2014/15